$8.83
1.70% yesterday
Nasdaq, Jul 24, 10:00 pm CET
ISIN
US86889P1093
Symbol
SRZN

Surrozen Inc Stock price

$8.83
-0.07 0.73% 1M
-2.48 21.90% 6M
-5.53 38.50% YTD
+0.45 5.31% 1Y
-42.48 82.80% 3Y
-142.83 94.18% 5Y
-142.83 94.18% 10Y
-142.83 94.18% 20Y
Nasdaq, Closing price Thu, Jul 24 2025
+0.15 1.70%
ISIN
US86889P1093
Symbol
SRZN
Industry

Key metrics

Basic
Market capitalization
$74.3m
Enterprise Value
$-27.4m
Net debt
positive
Cash
$101.7m
Shares outstanding
8.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
6.4 | 145.7
EV/Sales
negative | negative
EV/FCF
1.5
P/B
13.1
Financial Health
Equity Ratio
-44.1%
Return on Equity
297.3%
ROCE
-24.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$11.6m | $510.0k
EBITDA
$-24.6m | $-56.1m
EBIT
$-26.0m | $-40.5m
Net Income
$-81.7m | $-53.3m
Free Cash Flow
$-18.2m
Growth (TTM | estimate)
Revenue
- | -95.2%
EBITDA
33.4% | -132.8%
EBIT
33.0% | -58.5%
Net Income
-117.4% | 16.1%
Free Cash Flow
48.0%
Margin (TTM | estimate)
Gross
-
EBITDA
-211.5% | -11,000.0%
EBIT
-223.1%
Net
-702.1% | -10,455.0%
Free Cash Flow
-156.4%
More
EPS
$-22.5
FCF per Share
$-2.1
Short interest
1.0%
Employees
42
Rev per Employee
$250.0k
Show more

Is Surrozen Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Surrozen Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Surrozen Inc forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Surrozen Inc forecast:

Buy
88%
Hold
13%

Financial data from Surrozen Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
12 12
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 15 15
5% 5%
130%
- Research and Development Expense 22 22
8% 8%
193%
-25 -25
33% 33%
-212%
- Depreciation and Amortization 1.34 1.34
26% 26%
12%
EBIT (Operating Income) EBIT -26 -26
33% 33%
-223%
Net Profit -82 -82
117% 117%
-702%

In millions USD.

Don't miss a Thing! We will send you all news about Surrozen Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Surrozen Inc Stock News

Neutral
GlobeNewsWire
2 months ago
Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and -incorporating novel discoveries related to requirements for efficient and selective Wnt pathway signaling SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the ...
Neutral
GlobeNewsWire
3 months ago
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration, with a focus on severe eye diseases, today announced financial results for the first quarter ended March 31, 2025, and provided a business ...
Negative
24/7 Wall Street
4 months ago
After struggling through a rough patch, the biotech industry seems to be staging a comeback.
More Surrozen Inc News

Company Profile

Surrozen, Inc. is a preclinical stage biotechnology company, which engages in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. It is also focused on developing tissue-specific antibodies designed to engage the body's existing biological repair mechanisms with potential application across multiple disease areas, including inflammatory bowel disease, hepatitis, eye diseases, hearing loss, lung and airway diseases, and certain neurological disorders. The company was founded on August 12, 2015 and is headquartered in South San Francisco, CA.

Head office United States
CEO Craig Parker
Employees 42
Founded 2015
Website www.surrozen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today